In mid-March, representatives from REDINN and CliniSciences met with NEOSETAC’s partners at the Karolinska Institute in Sweden. The group included representatives from REDINN, CliniSciences, and the Karolinska Institute. This group discussed the technical details of NEOSETAC’s revolutionary nanoparticle drug delivery system. During the secondment, the CliniSciences team analyzed the size and shape of the nano particles filled with different combinations of drugs. These nanoparticles were created by our partners at Universitat Autònoma de Barcelona (UAB). Once the nanoparticles are verified, they can then be used for cell culture toxicity experiments.

A video recording was made of the meeting. This video will be cut and released in small chunks that will detail specific parts of the project for easy consumption.